• Explore /
  • Poster
  • / Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC).

Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC).

Abstract Poster

Authors

Lillian Siu

Lillian L. Siu

Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Lillian L. Siu , Joshua Bauml , Douglas Adkins , A. Dimitrios Colevas , Cesar Augusto Perez , Jennifer Hsing Choe , Yang Zhang , Wen Shi , Willis H. Navarro , Missak Haigentz Jr., Guilherme Rabinowits , David G. Pfister

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT03769467

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS6092)

DOI

10.1200/JCO.2019.37.15_suppl.TPS6092

Abstract #

TPS6092

Poster Bd #

79b

Abstract Disclosures

Similar Posters

First Author: A. Dimitrios Colevas

First Author: Christophe Le Tourneau

First Author: Man Jiang

First Author: Hsiang-fong Kao